Publikationen von Dilloo, Dagmar

Corbacioglu, Selim , Lode, Holger, Ellinger, Susanne, Zeman, Florian, Suttorp, Meinolf, Escherich, Gabriele, Bochennek, Konrad, Gruhn, Bernd, Lang, Peter, Rohde, Marius, Debatin, Klaus Michael, Steinbach, Daniel, Beilken, Andreas, Ladenstein, Ruth, Spachtholz, Rainer, Heiss, Peter, Hellwig, Dirk , Tröger, Anja, Koller, Michael , Menhart, Karin , Riemenschneider, Markus J. , Zoubaa, Saida, Kietz, Silke, Jakob, Marcus, Sommer, Gunhild , Heise, Tilman , Hundsdörfer, Patrick, Kühnle, Ingrid, Dilloo, Dagmar, Schönberger, Stefan, Schwabe, Georg, von Luettichau, Irene, Graf, Norbert, Schlegel, Paul-Gerhardt, Frühwald, Michael, Jorch, Norbert, Paulussen, Michael, Schneider, Dominik T., Metzler, Markus, Leipold, Alfred, Nathrath, Michaela, Imschweiler, Thomas, Christiansen, Holger, Schmid, Irene, Crazzolara, Roman, Niktoreh, Naghmeh, Cario, Gunnar, Faber, Joerg, Demmert, Martin, Babor, Florian, Fröhlich, Birgit, Bielack, Stefan, Bernig, Toralf, Greil, Johann, Eggert, Angelika, Simon, Thorsten und Foell, Juergen (2024) Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial. The Lancet Oncology 25 (7), S. 922-932.

Schoen, Leonie F., Craveiro, Rogerio B., Pietsch, Torsten, Moritz, Thomas, Troeger, Anja, Jordans, Silvia und Dilloo, Dagmar (2022) The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitro. Journal of Cellular and Molecular Medicine 26 (23), S. 5832-5845.

Karremann, Michael , Krämer, Nadja, Hoffmann, Marion, Wiese, Maria, Beilken, Andreas, Corbacioglu, Selim, Dilloo, Dagmar, Driever, Pablo Hernáiz, Scheurlen, Wolfram, Kulozik, Andreas, Gielen, Gerrit H., von Bueren, André O., Dürken, Matthias und Kramm, Christof M. (2017) Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. European Journal of Cancer 81, S. 1-8. Volltext nicht vorhanden.